Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Christian Dubiella(Weizmann Institute of Science), Benika J. Pinch(Harvard University), Kazuhiro Koikawa(Broad Institute), Daniel Zaidman(Weizmann Institute of Science), Evon Poon(Institute of Cancer Research), Theresa Manz(Harvard University), Behnam Nabet(Harvard University), Shuning He(Harvard University), Efrat Resnick(Weizmann Institute of Science), Adi Rogel(Weizmann Institute of Science), Ellen M. Langer(Oregon Health & Science University), Colin J. Daniel(Oregon Health & Science University), Hyuk‐Soo Seo(Dana-Farber Cancer Institute), Ying Chen(Peking University), Guillaume Adelmant(Brigham and Women's Hospital), Shabnam Sharifzadeh(Brigham and Women's Hospital), Scott B. Ficarro(Brigham and Women's Hospital), Yann Jamin(Institute of Cancer Research), Barbara Martins Da Costa(Institute of Cancer Research), Mark W. Zimmerman(Harvard University), Xiaolan Lian(Broad Institute), Shin Kibe(Broad Institute), Shingo Kozono(Broad Institute), Zainab M. Doctor(Harvard University), Christopher M. Browne(Harvard University), Annan Yang(Dana-Farber Cancer Institute), Liat Stoler‐Barak(Weizmann Institute of Science), Richa B. Shah(The Graduate Center, CUNY), Nicholas E. Vangos(Dana-Farber Cancer Institute), Ezekiel A. Geffken(Dana-Farber Cancer Institute), Roni Oren(Weizmann Institute of Science), Eriko Koide(Harvard University), Samuel Sidi(The Graduate Center, CUNY), Ziv Shulman(Weizmann Institute of Science), Chu Wang(Peking University), Jarrod A. Marto(Brigham and Women's Hospital), Sirano Dhe‐Paganon(Dana-Farber Cancer Institute), Thomas Look(Boston Children's Hospital), Xiao Zhen Zhou(Broad Institute), Kun Ping Lu(Broad Institute), Rosalie C. Sears(Oregon Health & Science University), Louis Chesler(Institute of Cancer Research), Nathanael S. Gray(Harvard University), Nir London(Weizmann Institute of Science)
Cited by 147Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis